NCT05494970

Brief Summary

Feasibility, prospective, monocentric study aiming to evaluate the interest of a written information guide, given and explained by the dental assistant, on the improvement of the oral hygiene of patients with ORL cancer at 3 months post-radiotherapy. The study will be conducted on a population of 44 patients with ORL cancer requiring radiation treatment. Each patient will be followed during 3 months post-radiotherapy (follow-up for up to 12 months post-inclusion).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 8, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 10, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

October 13, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
Last Updated

February 7, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

August 8, 2022

Last Update Submit

February 5, 2024

Conditions

Keywords

ORL CancerOral hygieneRadiotherapyWritten information guide

Outcome Measures

Primary Outcomes (1)

  • Rate of patients with improved oral hygiene between the inclusion visit and 3 months post-radiotherapy.

    Improvement is defined as a gross decrease of at least 30% in the plaque index between the inclusion visit and 3 months post-radiotherapy. The plaque index will be evaluated using the O'Leary method.

    3 months per patient

Secondary Outcomes (2)

  • Patient satisfaction with the oral hygiene information guide and the consultations performed by the dental assistant.

    3 months per patient

  • The motivation of the patients towards their oral health.

    3 months per patient

Study Arms (1)

Patients with ORL cancer for which radiotherapy treatment is required.

Other: Accompaniment by the dental assistant.

Interventions

Inclusion visit (before radiotherapy treatment): * oral hygiene education (prevention of complications related to radiotherapy) will be provided by the dental assistant. * a written information guide on oral hygiene will be given to the patient. * the questionnaire entitled "Motivation and oral hygiene behavior" will be completed by the patient. End of study visit (three months post-radiotherapy): • The "Motivation and oral hygiene behavior" and the satisfaction questionnaires will be completed by the patient.

Patients with ORL cancer for which radiotherapy treatment is required.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient with ORL cancer for which radiotherapy (+/- associated chemotherapy) is indicated.

You may qualify if:

  • Age ≥ 18 years at study entry.
  • Patient with ORL cancer requiring radiotherapy (+/- associated chemotherapy).
  • Patient with a plaque index \> or = 30%.
  • Patient affiliated to a social security system in France.

You may not qualify if:

  • Pregnant or lactating women.
  • Any psychological, familial, geographic or sociological condition that does not allow for compliance with the medical follow-up and/or procedures outlined in the study protocol.
  • Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Universitaire du Cancer Toulouse - Oncopole

Toulouse, 31059, France

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2022

First Posted

August 10, 2022

Study Start

October 13, 2022

Primary Completion

January 30, 2024

Study Completion

January 30, 2024

Last Updated

February 7, 2024

Record last verified: 2024-02

Locations